Skip to main content

Advertisement

Table 2 Clinical characteristics responders

From: Prevalence, impact and care of foot problems in people with rheumatoid arthritis: results from a United Kingdom based cross-sectional survey

Demographic and clinical characteristics responders (n = 413)
Disease duration median years (IQR)   10 (5 to 20)
Age at diagnosis mean years (SD)   50.3 (14.9)
Arthritis medications number (%) NSAIDs 128 (31.0)
DMARDs 339 (82.1)
Glucocorticoids 122 (29.5)
Biologics 74 (17.9)
HAQ median score (IQR)b   1.5 (0.75 to 2.0)
FIS median score (IQR)a b FISIF 10 (6 to 14)
FISAP 16 (7 to 23)
Importance median score (IQR)a   6 (3 to 8)
Cope median score (IQR)a   5 (3 to 7)
Severity median score (IQR)a   6 (3 to 8)
Impact of foot problems on ability to work number (%) Yes 156 (37.8)
No 98 (23.7)
Not applicable 159 (38.5)
Time interval of last recalled foot examination number (%)b 0–6 months 89 (21.6)
> 6–12 months 61 (14.8)
> 12–18 months 34 (8.3)
> 18 months 97 (23.5)
Can’t remember 31 (7.5)
Never had feet examined 100 (24.3)
  1. a FIS IF Foot Impact Score foot impairment/ footwear restriction subscale, FIS AP FIS activity limitation/participation restriction subscale; Importance = importance of foot problems; Cope = ability to cope with foot problems; Severity = severity of foot problems
  2. bHAQ admissible n = 404; FIS admissible n = 400; foot examination admissible n = 412; IQR = Interquartile range